SAN CARLOS, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) President and CEO Howard W. Robin is scheduled to present at the upcoming Natixis Bleichroeder Second Annual Hidden Gems Conference in New York at the Waldorf-Astoria Hotel on Monday, October 13, 2008 at 2:30 p.m. ET.
The presentation will be accessible via Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until October 27, 2008.
Nektar Therapeutics is a biopharmaceutical company that develops and
enables differentiated therapeutics with its industry-leading PEGylation
and pulmonary drug development technology platforms. Nektar PEGylation and
pulmonary technology, expertise, manufacturing capabilities have enabled
eight approved products for partners, which include the world's leading
pharmaceutical and biotechnology companies. Nektar also develops its own
products by applying its PEGylation and pulmonary technology platforms to
existing medicines with the objective to enhance performance, such as
improving efficacy, safety and compliance.
|SOURCE Nektar Therapeutics|
Copyright©2008 PR Newswire.
All rights reserved